Physician profile
Diego Villacis
NPI 1124399449
$56,992.97
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $3,379 · 2021: $10K · 2022: $4,280 · 2023: $1,486 · 2024: $25K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $5,526 · Food and Beverage: $1,713 · Gift: $39.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,235.00 |
| Travel and Lodging | $5,525.59 |
| Food and Beverage | $1,713.42 |
| Gift | $39.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $34,635.11 | 2019-2025 | Inset System |
| Stryker Corporation | $15,570.02 | 2020-2025 | Aequalis Perform, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Medical Device Business Services, INC. | $2,625.00 | 2024 | |
| Wright Medical Technology, INC. | $1,825.67 | 2019-2020 | |
| Great Lakes Orthopedics | $1,200.00 | 2021 | |
| Medwest Associates | $542.00 | 2020 | |
| Arthrex, INC. | $211.80 | 2019-2022 | |
| Smith+Nephew, INC. | $132.99 | 2022 | |
| Encore Medical, LP | $121.36 | 2019 | |
| Fx Shoulder Solutions, INC | $114.96 | 2023 | |
| Globus Medical, INC. | $14.06 | 2024 | Clavicular Fracture Fixation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Villacis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.